![NCI Frederick Laboratory's $400 Million Per Year Contract Up for Re-Competition](https://cdn.cancerletter.com/media/2015/06/26050238/41-23-NCI-Frederick-Laboratorys-400-Million-Per-Year-Contract-Up-for-Re-Competition.jpg)
![NCI Frederick Laboratory's $400 Million Per Year Contract Up for Re-Competition](https://cdn.cancerletter.com/media/2015/06/26050238/41-23-NCI-Frederick-Laboratorys-400-Million-Per-Year-Contract-Up-for-Re-Competition.jpg)
Cover Story
NCI is opening up its contract for operations and technical support at the Frederick National Laboratory for Cancer Research for re-competition—a process that officials said will take up to two years.
By Nick Crispino
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Drugs & Targets
Trending Stories
- Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center
- A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement. - At Lung SPORE Workshop, experts reflect on the significance of discovery of EGFR mutations two decades ago
- The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop